Journals Progress in Cardiovascular Dis...

Progress in Cardiovascular Diseases
Gregory L Stonerock, Rahul P Gupta, James A Blumenthal
OBJECTIVES: Exercise has been promoted as a treatment for a variety of psychiatric conditions. The benefits of exercise for depression are widely recognized, but the benefits of exercise for anxiety are uncertain. Although several reviews promoted exercise as a treatment for anxiety, concerns about the quality of studies prompted us to provide a critical review of the recent literature to re-assess the value of exercise for treating anxiety. METHODS AND MATERIALS: We conducted a systematic review of all peer-reviewed randomized clinical trials (RCTs) among adults, published between January 2014 and December 2021, with an exercise intervention and anxiety as the a priori primary outcome...
May 25, 2023: Progress in Cardiovascular Diseases
Ebenezer Aryee, Bige Ozkan, Chiadi E Ndumele
The marked rise in rates of obesity, which is most prominent among individuals from socio-economically disadvantaged circumstances, has been a powerful contributor to the rising prevalence of heart failure (HF). Obesity has indirect effects on HF through the development of several metabolic risk factors, but also direct adverse effects on the myocardium. Obesity contributes to myocardial dysfunction and HF risk through multiple mechanisms, including hemodynamic changes, neurohormonal activation, endocrine and paracrine effects of adipose tissue, ectopic fat deposition and lipotoxicity...
May 24, 2023: Progress in Cardiovascular Diseases
Alejandra Meza Contreras, Darrell B Newman, Lucio Cappelloni, Alexander S Niven, Michael R Mueller, Ravindra Ganesh, Ray W Squires, Amanda R Bonikowske, Thomas G Allison
BACKGROUND: Dyspnea and fatigue are characteristics of long SARS-CoV-2 (COVID)-19. Cardiopulmonary exercise testing (CPET) can be used to better evaluate such patients. RESEARCH QUESTION: How significantly and by what mechanisms is exercise capacity impaired in patients with long COVID who are coming to a specialized clinic for evaluation? STUDY DESIGN AND METHODS: We performed a cohort study using the Mayo Clinic exercise testing database...
May 19, 2023: Progress in Cardiovascular Diseases
Robyn Bryde, Matthew W Martinez, Michael S Emery
Individuals with hypertrophic cardiomyopathy (HCM) have historically been advised to limit exercise and sports participation to mild-intensity activities due to concerns for sudden cardiac arrest (SCA). However, more contemporary data have shown SCA is rare in patients with HCM and emerging data is shifting towards support for the safety of exercise in this patient population. Recent guidelines endorse exercise in patients with HCM after a comprehensive evaluation and shared-decision making with an expert provider...
May 16, 2023: Progress in Cardiovascular Diseases
Andrew S Baez, Lola R Ortiz-Whittingham, Hannatu Tarfa, Foster Osei Baah, Keitra Thompson, Yvonne Baumer, Tiffany M Powell-Wiley
Social determinants of health (SDoH), or the socioeconomic, environmental, and psychosocial conditions in which individuals spend their daily lives, substantially influence obesity as a cardiovascular disease (CVD) risk factor. The coronavirus disease 2019 (COVID-19) pandemic highlighted the converging epidemics of obesity, CVD, and social inequities globally. Obesity and CVD serve as independent risk factors for COVID-19 severity and lower-resourced populations most impacted by adverse SDoH have the highest COVID-19 mortality rates...
May 11, 2023: Progress in Cardiovascular Diseases
Andrea M Yeung, Jingtong Huang, Ambarish Pandey, Ibrahim A Hashim, David Kerr, Rodica Pop-Busui, Connie M Rhee, Viral N Shah, Lia Bally, Antoni Bayes-Genis, Yong Mong Bee, Richard Bergenstal, Javed Butler, G Alexander Fleming, Gregory Gilbert, Stephen J Greene, Mikhail N Kosiborod, Lawrence A Leiter, Boris Mankovsky, Thomas W Martens, Chantal Mathieu, Viswanathan Mohan, Kershaw V Patel, Anne Peters, Eun-Jung Rhee, Giuseppe M C Rosano, David B Sacks, Yader Sandoval, Jane Jeffrie Seley, Oliver Schnell, Guillermo Umpierrez, Kayo Waki, Eugene E Wright, Alan H B Wu, David C Klonoff
Diabetes Technology Society assembled a panel of clinician experts in diabetes, biomarker screening, and heart failure to review the current evidence on biomarker screening of people with diabetes (PWD) for heart failure (HF), who are, by definition, at risk for HF (Stage A HF). This consensus report reviews features of HF in PWD from the perspectives of 1) epidemiology, 2) classification of stages, 3) pathophysiology, 4) biomarkers for diagnosing, 5) biomarker assays, 6) diagnostic accuracy of biomarkers, 7) benefits of biomarker screening, 8) consensus recommendations for biomarker screening, 9) stratification of Stage B HF, 10) echocardiographic screening, 11) management of Stage A and Stage B HF, and 12) future directions...
May 11, 2023: Progress in Cardiovascular Diseases
Ian J Neeland
No abstract text is available yet for this article.
May 6, 2023: Progress in Cardiovascular Diseases
Katherine Chiswell, Louisa Zaininger, Christopher Semsarian
Studies over the last 30 years have identified hypertrophic cardiomyopathy (HCM) as predominantly an autosomal dominant disorder caused by disease-causing variants in genes encoding the sarcomere proteins critical for contractile function. The two most common disease genes implicated are the MYBPC3 and MYH7 genes, with disease-causing variants in these two genes accounting for 70-80% of all genotype-positive HCM patients. This increased knowledge of the genetic basis of HCM has heralded the era of precision medicine, with genetic testing leading to more improved and precise diagnosis, effective cascade genetic testing in at-risk family members, assistance with reproductive decisions, targeted therapeutics guided by both phenotype and genotype, and providing important insights into risk stratification and prognosis...
May 1, 2023: Progress in Cardiovascular Diseases
Melissa E Middeldorp, Suraya H Kamsani, Prashanthan Sanders
The prevalence of atrial fibrillation (AF) and obesity are rising significantly. There is a shared association between these conditions with obesity predisposing individuals to a number of shared risk factors. In addition, obesity in itself has been shown to cause changes to the structure, function and hemodynamics of the heart. There is evidence to show that weight-loss has significant impact on AF symptoms, burden and more recently the potential to reverse the type of AF. Through risk factor management and in the case of morbid obesity, bariatric surgery, there is an improved prognosis for patients with AF and obesity...
April 28, 2023: Progress in Cardiovascular Diseases
Veronica R Johnson, Chika V Anekwe, Tiffani Bell Washington, Shradha Chhabria, Lucy Tu, Fatima Cody Stanford
While the prevalence of obesity in US men and women is nearly equivalent, obesity management in women requires a different approach that considers age and life stage in development including sexual maturation/reproduction, menopause and post-menopause. In this review, the diagnosis and treatment of obesity using lifestyle modification, pharmacotherapy and metabolic and bariatric surgery are discussed from a women's health perspective, with emphasis on management during pregnancy and post-partum.
April 27, 2023: Progress in Cardiovascular Diseases
Ameesh Isath, Klaudia J Koziol, Matthew W Martinez, Carol Ewing Garber, Matthew N Martinez, Michael S Emery, Aaron L Baggish, Srihari S Naidu, Carl J Lavie, Ross Arena, Chayakrit Krittanawong
Cardiovascular (CV) disease (CVD) is the leading cause of global morbidity and mortality, and low levels of physical activity (PA) is a leading independent predictor of poor CV health and associated with an increased prevalence of risk factors that predispose to CVD development. In this review, we evaluate the benefits of exercise on CV health. We discuss the CV adaptations to exercise, focusing on the physiological changes in the heart and vasculature. We review the impact and benefits of exercise on specific CV prevention, including type II diabetes, hypertension, hyperlipidemia, coronary artery disease, and heart failure, in addition to CVD-related and all-cause mortality...
April 27, 2023: Progress in Cardiovascular Diseases
Gianluca Iacobellis
Patients with obesity have been historically associated with higher risk to develop cardiovascular diseases (CVD). However, regional, visceral, organ specific adiposity seems to play a stronger role in the development of those cardiovascular diseases than obesity by itself. Epicardial adipose tissue is the visceral fat depot of the heart with peculiar anatomy, regional differences, genetic profile and functions. Due to its unobstructed contiguity with heart and intense pro inflammatory and pro arrhythmogenic activities, epicardial fat is directly involved in major obesity-related CVD complications, such as coronary artery disease (CAD), atrial fibrillation (AF) and heart failure (HF)...
April 25, 2023: Progress in Cardiovascular Diseases
Alan Rozanski
No abstract text is available yet for this article.
April 18, 2023: Progress in Cardiovascular Diseases
Alan Rozanski, James A Blumenthal, Alan L Hinderliter, Steven Cole, Carl Lavie
Poor lifestyle habits, such as physical inactivity and poor diets, are highly prevalent within society and even more so among patients with chronic disease. The need to stem poor lifestyle habits has led to the development of a new field of Lifestyle Medicine, whose mission is to prevent, treat, and even reverse chronic diseases through lifestyle interventions. Three fields within Cardiology relate to this mission: Cardiac Rehabilitation, Preventive Cardiology, and Behavioral Cardiology. Each of these three fields have contributed substantially to the reduction of cardiovascular disease (CVD) morbidity and mortality...
April 12, 2023: Progress in Cardiovascular Diseases
Ian J Neeland, Carl J Lavie
No abstract text is available yet for this article.
April 11, 2023: Progress in Cardiovascular Diseases
Alan Rozanski
The larger number of adults who enter their senior years with a high burden of chronic diseases has led to new metrics designed to promote health pro-activity, such as the calculation of one's "healthspan". These efforts call for re-evaluation as to what is meant by "health". A large body of epidemiologic and clinical investigation identifies that good health is shaped by specific health behaviors (aerobic exercise, resistance training, sleep, and good diet quality) and four psychological determinants (positive emotions, positive mindsets, purposeful living, and social connectivity)...
April 8, 2023: Progress in Cardiovascular Diseases
Alan Rozanski
The modern environment has led to an increased risk and incidence of sedentary lifestyles. When physical activity (PA) becomes insufficient, pathophysiological pathways are invoked and the future risk for chronic diseases and premature mortality increases. As a consequence, since the 1970s governmental agencies and medical societies have published guidelines to promote PA. The 2018 Guidelines for Physical Activity for Americans contain important updated guidelines, but many of these guidelines are not yet sufficiently known by the public or health providers...
April 6, 2023: Progress in Cardiovascular Diseases
Ross Arena, Grenita Hall, Deepika R Laddu, Shane A Phillips, Tanvi Bhatt, Mark Faghy, Carl J Lavie
No abstract text is available yet for this article.
March 27, 2023: Progress in Cardiovascular Diseases
Tasveer Khawaja, Jennifer Linge, Olof D Leinhard, Sadeer G Al-Kindi, Sanjay Rajagopalan, Amit Khera, James A de Lemos, Parag Joshi, Ian J Neeland
INTRODUCTION: Cardiovascular disease (CVD) risk amongst those with type 2 diabetes (T2D) is heterogenous. The role of imaging-based cardiometabolic biomarkers (e.g., coronary artery calcium [CAC] score, and hepatic triglyceride content [HTC]) in CVD risk stratification in T2D is unclear. To better understand this, we sought to evaluate the individual and joint associations between CAC and hepatic steatosis (HS) with clinical atherosclerotic CVD (ASCVD) in Dallas Heart Study (DHS) participants with and without T2D...
March 15, 2023: Progress in Cardiovascular Diseases
Alan Rozanski, Sakul Sakul, Jagat Narula, Seth Uretsky, Carl J Lavie, Daniel Berman
Cardiac stress tests have been widely utilized since the 1960s for the diagnostic and prognostic assessment of patients with suspected coronary artery disease (CAD). Clinical risk is primarily based on assessing the presence and magnitude of inducible myocardial ischemia. However, the primary factors driving mortality risk have changed over recent decades. Factors such as typical angina and inducible ischemia have decreased, whereas the percentage of patients with diabetes, obesity and hypertension have increased...
March 15, 2023: Progress in Cardiovascular Diseases
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.